Drug Profile
Research programme: sigma 1 receptor antagonists - Neurotech
Alternative Names: NP-07; NP-2007Latest Information Update: 28 Aug 2012
Price :
$50
*
At a glance
- Originator Neurotech Pharmaceuticals
- Developer GNT Pharma
- Class
- Mechanism of Action Glutamate agonists; Sigma-1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Neuropathic pain; Pain
Most Recent Events
- 28 Aug 2012 No development reported - Preclinical for Neuropathic pain in South Korea (unspecified route)
- 28 Aug 2012 No development reported - Preclinical for Pain in South Korea (unspecified route)
- 22 Aug 2007 Preclinical trials in Neuropathic pain in South Korea (unspecified route)